NerPharMa is an Italian CDMO (part of NMS Group, acquired by Benta in 2026) specializing in highly potent compounds with strong expertise in oncology. It operates two divisions: Drug Substance (API manufacturing in high containment glove-box suites, 50-250L reactors, 0.5-5 kg batches) and Drug Product (injectable solutions, suspensions, lyophilized products, and oral solid dosage forms including cytotoxic and cytostatic products).
highly potent API manufacturing, oncology CDMO, high containment glove-box technology, cytotoxic drug product manufacturing, lyophilized injectables
1 site worldwide
No reviews available yet.
No documents available.